Topics

AZ outlines plans to advance global R&D for new drugs in China

04:44 EST 7 Nov 2019 | SmartBrief

AstraZeneca has picked China as its collaborator to launch three massive programs that will advance its research and developm -More

Original Article: AZ outlines plans to advance global R&D for new drugs in China

NEXT ARTICLE

More From BioPortfolio on "AZ outlines plans to advance global R&D for new drugs in China"

Quick Search

Relevant Topic

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...